O'Dell Group’s Asensus Surgical, Inc. ASXC Stock Holding History

O'Dell Group’s Portfolio ASXC Stock Details ASXC Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q1	–	Sell	-77	Closed	-$25	–	509
2023 Q4	$25	Buy	+77	New	+$20	﹤0.01%	506
2023 Q3	–	Sell	-77	Closed	-$39	–	515
2023 Q2	$39	Buy	+77	New	+$46	﹤0.01%	515
2022 Q4	–	Sell	-77	Closed	–	–	429
2022 Q3	$0	Hold	77	–	–	﹤0.01%	507
2022 Q2	$0	Sell	77 -177	-70%	-$79	﹤0.01%	582
2022 Q1	$0	Hold	254	–	–	﹤0.01%	592
2021 Q4	$0	Hold	254	–	–	﹤0.01%	555
2021 Q3	$0	Buy	+254	New	+$570	﹤0.01%	512

Other funds holding ASXC

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

MCM

Masters Capital Management Atlanta, Georgia $3.9B AUM 50.88% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return

Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return

Osaic Holdings Scottsdale, Arizona $85.1B AUM 27.35% 1-Year Est. Return

Jane Street New York $1.21T AUM 78.12% 1-Year Est. Return

AlphaCentric Advisors San Juan, Puerto Rico $118M AUM

O'Dell Group's ASXC Position: Q1 2024 in Review

O'Dell Group sold out of Asensus Surgical, Inc. (ASXC) in Q1 2024, closing a stake of 77 shares — an estimated $25 sold.

O'Dell Group first reported a position in ASXC in Q3 2021 and held it in 7 quarters. The position peaked at $39 in Q2 2023. 72 funds tracked by Wall St. Rank hold ASXC as of Q1 2024.

O'Dell Group reported no remaining Asensus Surgical, Inc. position as of Q1 2024 after selling out during the quarter.
O'Dell Group sold 77 Asensus Surgical, Inc. shares in Q1 2024, an estimated $25.
O'Dell Group first reported a position in Asensus Surgical, Inc. in Q3 2021 and held it in 7 quarters.
O'Dell Group's Asensus Surgical, Inc. position peaked at $39 in Q2 2023.
72 funds tracked by Wall St. Rank held Asensus Surgical, Inc. as of Q1 2024.

Based on O'Dell Group's 13F filing for Q1 2024, filed 7 May 2024.